Virus-fighting company aimed at knocking out HIV raises $60M

The company uses the CRISPR genome-editing technology, developed by a Nobel Prize-winning UC Berkeley scientist.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.